[Stefan Jørgensen 1887-1944: a clearing-murder]. / Stefan Jørgensen 1887-1944. Et clearing-mord.

In Domus Medica, there is a white marble plaque with the names of Danish doctors who lost their lives during the occupation. Among these names is my father's "Stefan Jørgensen". The murder of my father was what is called a 'clearing' murder, i.e., the murder of a Dane chosen at random as retaliation for the killing of a German or an informer. My father was murdered at the door of his consulting rooms in his home on 24 April 1944. An article in Berlingske Tidende on 25 April stated that the murder occurred in the doctor's consulting rooms, where in the end two young men and a somewhat older man sat in the waiting room. When the doctor came out to receive the next patient, one of the younger men got up and shot at the doctor's head four times, where upon the doctor fell down, and the murderer fled. In 1993, a book by Jørgen Røjel, "Holger Danske rejser sig", was published. In the book is stated, On 24 April "Johs' father was murdered by Henning Brøndum". Hans Edvard Teglers writes in his book "Sabotage" from 1961, "On 24 April 1944, Doctor Stefan Jørgensen was murdered in his consulting rooms in Vaeldegaardsvej in Gentofte. The two terrorists, Brøndum and Bothilsen Nielsen, had sat in the waiting room. It later came to light that Dr. Stefan Jørgensen had been on the Gestapo's list of possible victims for the so-called 'clearing murders', the so-called A-file".

[The insulin preparation - Diasulin - that annoyed August Krogh]. / Insulinpraeparatet - Diasulin - som aergrede August Krogh.

After the two Canadian researchers, Banting and Best, had succeeded in extracting the pancreatic hormone, insulin, from bovine pancreatic tissue in 1921, August and Marie Krogh brought insulin to Denmark on 12 December 1922. With H.C. Hagedorn, who at the time was senior registrar in the III Department of Kobenhavns Kommunehospital (Copenhagen Municipal Hospital), August Krogh immediately began experiments to produce insulin, and already on 21 December, they succeeded in isolating a small amount of insulin from a bovine pancreas. August Kongsted, owner of Lovens Kemiske Fabrik (Leo Chemical Factory), paid the expenses for the experiments and afterwards helped to start the production of >>Insulin Leo<<. At the start, there was not enough insulin to treat all the diabetics in Denmark, and since Hagedorn was employed in the III Department of Kobenhavns Kommunehospital, this department was the first that had insulin at its disposal. Krogh made it clear that it would probably take several months, maybe even a year, before insulin would be available for all the diabetics in the country. The II Department of Kobenhavn Kommunehospital could not accept this, and as early as May 1923, this department began to treat diabetics with Diasulin Medicinalco, a pancreatic hormone preparation manufactured by H. L. Gad Andresen at Det Danske Medicinal- og Kemikalie-Kompagni (Danish Medicine and Chemical Company). Later Det Danske Medicinal- og Kemikalie-Kompagni began to sell Diasulin under the name Isulin Medicinalco.

[Mass radiography via mammography in women with enhanced risk of cancer of the breast (author's transl)]. / Reihenuntersuchungen bei Frauen mit einem erhöhten Risiko für eine Brustkrebserkrankung mit Hilfe der Mammographie.

Mammographic and clinical examination of 1,751 women with one or several risk factors of the screening programme revealed 5.2% carcinomas but only 1.6% occult carcinomas. The results are not better than those of mass radiographies of non-selected groups of women. The article discusses the course of the examination, radiation load, frequency rates of mastopathies and their relation to endocrinological factors, as well as cost and procedure.

[Percutaneous demonstration of lactiferous ducts in benign breast tumours. The use of contrast in the diagnosis of breast tumours such as fibroadenomas and proliferative mastopathies (author's transl)]. / Die perkutane Darstellung von Milchgängen in gutartigen Mammatumoren. Eine erweiterte Kontrastmittelanwendung in der Mammatumordiagnostik am Beispiel von Fibroadenomen und proliferlerender Mastopathie

A new method is described which makes it possible to demonstrate the duct system in fibroadenomas and mastopathies by percutaneous injection of contrast. In this way, the pre-operative diagnosis of benign breast tumours can be confirmed. The technique is described and the early results are illustrated.